Terms: = Breast cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Prognosis
26 results:
1. N
Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of miR-600 with wt1 expression and its potential clinical significance in breast cancer.
Pishbin F; Ziamajidi N; Abbasalipourkabir R; Najafi R; Farhadian M
Per Med; 2021 Jan; 18(1):31-42. PubMed ID: 33393369
[No Abstract] [Full Text] [Related]
3. Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes.
Deman F; Punie K; Laenen A; Neven P; Oldenburger E; Smeets A; Nevelsteen I; Van Ongeval C; Baten A; Faes T; Christiaens M; Janssen H; Weltens C; Desmedt C; Wildiers H; Floris G
Breast Cancer Res Treat; 2020 Dec; 184(3):985-998. PubMed ID: 32920743
[TBL] [Abstract] [Full Text] [Related]
4. The role of wt1 in breast cancer: clinical implications, biological effects and molecular mechanism.
Zhang Y; Yan WT; Yang ZY; Li YL; Tan XN; Jiang J; Zhang Y; Qi XW
Int J Biol Sci; 2020; 16(8):1474-1480. PubMed ID: 32210734
[TBL] [Abstract] [Full Text] [Related]
5. breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.
Della Corte L; Giampaolino P; Fabozzi A; Cieri M; Zizolfi B; Morra I; Bifulco G
Gynecol Endocrinol; 2019 Mar; 35(3):211-213. PubMed ID: 30449229
[TBL] [Abstract] [Full Text] [Related]
6. wt1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer.
McGregor RJ; Chau YY; Kendall TJ; Artibani M; Hastie N; Hadoke PWF
Br J Cancer; 2018 Dec; 119(12):1508-1517. PubMed ID: 30374123
[TBL] [Abstract] [Full Text] [Related]
7. The Challenge of Evaluating Adnexal Masses in Patients With breast cancer.
Reinert T; Nogueira-Rodrigues A; Kestelman FP; Ashton-Prolla P; Graudenz MS; Bines J
Clin Breast Cancer; 2018 Aug; 18(4):e587-e594. PubMed ID: 29680194
[TBL] [Abstract] [Full Text] [Related]
8. The role of wt1 isoforms in vasculogenic mimicry and metastatic potential of human triple negative breast cancer cells.
Bissanum R; Lirdprapamongkol K; Svasti J; Navakanitworakul R; Kanokwiroon K
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):256-262. PubMed ID: 29024629
[TBL] [Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
[TBL] [Abstract] [Full Text] [Related]
10. wt1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.
Artibani M; Sims AH; Slight J; Aitken S; Thornburn A; Muir M; Brunton VG; Del-Pozo J; Morrison LR; Katz E; Hastie ND; Hohenstein P
Sci Rep; 2017 Mar; 7():45255. PubMed ID: 28345629
[TBL] [Abstract] [Full Text] [Related]
11. Identifying the role of Wilms tumor 1 associated protein in cancer prediction using integrative genomic analyses.
Wu LS; Qian JY; Wang M; Yang H
Mol Med Rep; 2016 Sep; 14(3):2823-31. PubMed ID: 27430156
[TBL] [Abstract] [Full Text] [Related]
12. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract] [Full Text] [Related]
13. Wilms' tumor 1 (wt1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
[TBL] [Abstract] [Full Text] [Related]
14. Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.
Stirzaker C; Zotenko E; Song JZ; Qu W; Nair SS; Locke WJ; Stone A; Armstong NJ; Robinson MD; Dobrovic A; Avery-Kiejda KA; Peters KM; French JD; Stein S; Korbie DJ; Trau M; Forbes JF; Scott RJ; Brown MA; Francis GD; Clark SJ
Nat Commun; 2015 Feb; 6():5899. PubMed ID: 25641231
[TBL] [Abstract] [Full Text] [Related]
15. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.
Craig DW; O'Shaughnessy JA; Kiefer JA; Aldrich J; Sinari S; Moses TM; Wong S; Dinh J; Christoforides A; Blum JL; Aitelli CL; Osborne CR; Izatt T; Kurdoglu A; Baker A; Koeman J; Barbacioru C; Sakarya O; De La Vega FM; Siddiqui A; Hoang L; Billings PR; Salhia B; Tolcher AW; Trent JM; Mousses S; Von Hoff D; Carpten JD
Mol Cancer Ther; 2013 Jan; 12(1):104-16. PubMed ID: 23171949
[TBL] [Abstract] [Full Text] [Related]
16. High Wilms' tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer.
Qi XW; Zhang F; Yang XH; Fan LJ; Zhang Y; Liang Y; Ren L; Zhong L; Chen QQ; Zhang KY; Zang WD; Wang LS; Zhang Y; Jiang J
Oncol Rep; 2012 Oct; 28(4):1231-6. PubMed ID: 22797561
[TBL] [Abstract] [Full Text] [Related]
17. Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer.
Nagai MA; Gerhard R; Salaorni S; Fregnani JH; Nonogaki S; Netto MM; Soares FA
Int J Oncol; 2010 Jul; 37(1):41-9. PubMed ID: 20514395
[TBL] [Abstract] [Full Text] [Related]
18. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
Yang L; Wei J; He S
Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
[TBL] [Abstract] [Full Text] [Related]
19. wt1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.
Netinatsunthorn W; Hanprasertpong J; Dechsukhum C; Leetanaporn R; Geater A
BMC Cancer; 2006 Apr; 6():90. PubMed ID: 16606472
[TBL] [Abstract] [Full Text] [Related]
20. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
[TBL] [Abstract] [Full Text] [Related]
[Next]
